Circadian Variation in Esophagogastric Variceal Bleeding in Cirrhosis
Key facts
- Who runs it
- Third Affiliated Hospital, Sun Yat-Sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 614 people enrolled
- Started
- 1 Jul 2025
- Ended
- 1 Nov 2026
- Type of study
- Observational
- Record updated
- 17 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Aged 18 years or older
- Clinically diagnosed with liver cirrhosis
- Evident signs of acute upper gastrointestinal bleeding, specifically acute upper gastrointestinal bleeding presenting as hematemesis
- Informed consent
Who cannot take part
- Non-variceal bleeding detected by gastroscopy
- Severe extrahepatic diseases with cardiac, pulmonary, renal or cerebral insufficiency, excluding hepatic encephalopathy, hepatorenal syndrome and hepatopulmonary syndrome caused by liver cirrhosis
- Comorbidity with malignant tumors other than primary liver cancer
- Pregnant or breastfeeding women
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is a multi-center bidirectional cohort study. The aim is to investigate the potential circadian rhythm of the bleeding pattern of gastric esophageal varices rupture in liver cirrhosis, as well as other related mechanisms and external influencing factors related to the timing. This will help to better prevent the occurrence or aggravation of the disease and provide more effective timing-based treatment and prevention strategies for patients.
The group in the trial
- Population with Cirrhosis-related Variceal Bleeding
Inclusion Criteria 1. Aged 18 years or above 2. Clinically diagnosed with liver cirrhosis 3. Presenting with overt acute upper gastrointestinal bleeding, specifically hematemesis 4. Informed consent obtained Exclusion Criteria (1) Non-variceal bleeding identified on gastroscopy (2) Severe extrahepatic diseases, including cardiopulmonary, renal, or cerebral insufficiency, excluding hepatic encephalopathy, hepatorenal syndrome, and hepatopulmonary syndrome secondary to liver cirrhosis (3) Concurrent malignancy other than primary liver cancer (4) Pregnant or breastfeeding women
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Circadian Variation in Esophagogastric Variceal Bleeding in Cirrhosis: A Prospective, Multicenter, Cross-Sectional Study
- Record updated
- 17 November 2026